Discussing the Impact of the Pandemic on the Management of Lung, Breast, Gastrointestinal and Genitourinary Cancers — Part 1: Interview with Dr Liu on the following topics:
Clinical care of patients with lung cancer amid the COVID-19 pandemic (00:00)
Case (Dr Liu): A woman in her early 60s with Stage IV non-small cell lung cancer (NSCLC) and an EGFR exon 19 deletion receives osimertinib as first-line therapy and develops COVID-19 (21:00)
Case (Dr Liu): A woman in her mid-60s with severe dyspnea is diagnosed with small cell lung cancer and COVID-19 (24:27)
Case (Dr Liu): A man in his early 60s presents with metastatic NSCLC and an EGFR mutation (27:57)
Risk of complications with immunotherapy and chemotherapy during the COVID-19 pandemic (30:32)
Impact of COVID-19 on the care of patients with lung cancer; role of telemedicine (34:54)
Long-term effects of COVID-19 on clinical research and new advances (42:24)
Podden och tillhörande omslagsbild på den här sidan tillhör Dr Neil Love. Innehållet i podden är skapat av Dr Neil Love och inte av, eller tillsammans med, Poddtoppen.